Hyperkatifeia and negative reinforcement drive alcohol addiction via dysregulated brain reward and stress systems, review finds.

Alcohol addiction (Alcohol Use Disorder - AUD) is a chronic relapsing disorder marked by compulsive seeking, loss of control, and hyperkatifeia (a sensitized negative emotional state) during withdrawal. Current treatments often struggle with the persistent negative emotional states that drive relapse. This review focuses on the neurobiological mechanisms underlying negative reinforcement, particularly hyperkatifeia, as a critical, often-neglected driver of AUD, highlighting the need to target these specific pathways for more effective interventions.

This review synthesizes current neurobiological research on alcohol addiction, focusing on the role of negative reinforcement and hyperkatifeia. It integrates findings across three stages of the addiction cycle and identifies key neurotransmitter systems and neuroanatomical substrates involved. The authors analyze existing literature to propose a framework for understanding how dysregulation of brain reward and stress systems drives compulsive alcohol seeking and perpetuates the disorder.

The review posits that alcohol addiction represents a break with homeostatic brain regulatory mechanisms, progressing through three stages of the addiction cycle. A key finding is that the withdrawal/negative affect stage, characterized by hyperkatifeia, becomes increasingly prominent, driving compulsive-like drug seeking via negative reinforcement. This hyperkatifeia is mediated by a decrease in brain reward system function, involving key neurotransmitters like dopamine and opioid peptides, and the recruitment/sensitization of brain stress systems. These stress systems include corticotropin-releasing factor (CRF), dynorphin, hypocretin, ghrelin, norepinephrine, and neuroimmune modulation. Neuroadaptations of the hypothalamic-pituitary-adrenal axis (HPA axis) and sensitization of glucocorticoid receptor signaling are hypothesized to trigger and maintain these changes. Additionally, anti-stress systems such as neuropeptide Y, nociceptin, endocannabinoids, and oxytocin may be compromised, contributing to hyperkatifeia. Neuroanatomical substrates for hyperkatifeia are primarily focused on the extended amygdala and elements of the basal ganglia. The review highlights cellular and molecular targets for genetic and epigenetic vulnerability within an allostasis framework, showing therapeutic promise for this often-neglected domain.